Hong Kong's UMP Healthcare FY loss widens on uneven corporate spending
Overview
Hong Kong healthcare services provider's fiscal yr revenue fell 1.4% yr/yr
Net loss attributable to owners widened to HK$74.6 mln from prior yr profit
Company's performance impacted by uneven corporate spending and clinic rationalisation
Outlook
Company did not provide specific financial guidance for the current or upcoming year
Result Drivers
CORPORATE SPENDING - Co said uneven corporate spending sentiment in Hong Kong, Macau and Chinese Mainland weighed on performance
CLINIC RATIONALISATION - Co said clinic rationalisation and rebranding in Hong Kong affected segment performance
FOSHAN START-UP COSTS - Adjusted EBITDA fell 21% to HK$75.2 mln as the new Foshan integrated healthcare centre incurred start-up and ramp-up costs
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
FY Revenue | HK$717 mln | ||
FY Net Loss Attributable | HK$74.60 mln |
Reuters Recommended Reads
Sept 24 - India's insurance overhaul: What changes and why it matters
Sept 23 - China's Longhui H1 revenue falls amid lower customer traffic
Sept 24 - UK's CVS Group full-year revenue rises on Australia expansion
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)